Private Equity

A private equity fund is normally established for the purpose of purchasing companies or assets with improvement potential, or distressed companies or assets, with the intention of enhancing their profitability and then realizing the investment. Behind the name private equity hide different types of equity funds, distinguished by the size of the companies in which they invest, the stage of the lifespan of the companies they enter, the types of assets and the nature of the investment.

LITIVEST & MORE

Private Equity |
April 2025

Lexington Co-Investment Partners VI
Lexington Capital Partners

Private Equity |
March 2025

Naftali Shaked Partners II
Naftali Group

Credit Fund |
January 2025

Antares Senior Loan Master Fund III
Antares Capital

Credit fund |
January 2025

IBI Tevel
IBI Investment House

Credit Fund |
January 2025

עברית

LITIVEST & MORE

Private Equity |
April 2025

Lexington Co-Investment Partners VI | Lexington Capital Partners

Private Equity |
March 2025

Clearlake Capital Partners VIII |
Clearlake Capital Group

Private Equity |
August 2024

StepStone (Luxembourg) SCA SICAV-RAIF – SPRIM | StepStone Group

Private Equity Fund | June 2024

Veritas Capital Fund IX |
Veritas Capital

Private Equity Fund | April 2024

New Mountain Partners VII (NMC)
New Mountain Capital

Private Equity Fund
| January 2024

TJC – The Resulote Fund VI |
The Jordan Company

Private Equity Fund | September 2023

Value Base Fund | Value Base Group

Private Equity Fund | September 2023

Levine Leichtman Capital Partners VII – Levine Leichtman Capital Partners

Private Equity Fund |
February 2023

HarbourVest Co-Investment Fund VI – Leader Feeder | Leader Private Capital

Private Equity Fund | December 2022

Clayton, Dubilier & Rice Fund XII (CD&R) | Clayton, Dubilier & Rice

Private Equity Fund | September 2022

Carlyle Partners VIII – Carlyle Group

Private Equity Fund | September 2022

Harel Alternative Co-Invest Private Equity Fund | Harel Insurance & Finance

Private Equity Fund | March 2022

LLCP Lower Middle Market Fund III – Levine Leichtman Capital Partners

Private Equity Fund | May 2021

Montreux Healthcare Fund |
Montreux Group Holdings

Private Equity Fund | October 2020

New Mountain Partners VI (NMC) |
New Mountain Capital

Private Equity Fund | July 2020

Clayton, Dubilier & Rice Fund XI (CD&R) | Clayton, Dubilier & Rice

Private Equity Fund | July 2020

Vestar VII – Vestar Capital Partners

Private Equity Fund | September 2019

Discliamer

The analyses published on this Website are based on data obtained by the analysis editor from fund managers which include answers to questionnaires provided to them, various documents provided by the fund on request, market and trading data from the trading systems, if any, and opinions that reflect the subjective point of view of the analysis editors alone, but which to not address the investment’s adequacy to the needs of a particular investor, or in general.
The editors of the analyses published on the Website are not obligated to update the analysis from time to time or at all, and therefore, each analysis contained on the Website is relevant as of the date of its preparation.
The analyses published on the Website do not constitute a recommendation to carry out transactions involving interests in funds, nor do they constitute an investment advice within the meaning of the Regulation of Investment Advice, Investment Marketing and Investment Portfolio Management Law, 5755-1995, or an offer to purchase interests in the funds under review.
An investment in an equity fund, by nature, involve risks, including risks arising from the character and terms of investments managed on behalf of the fund, the manner of managing them as well as risks beyond the control of the fund, such as risks arising from macroeconomic changes. It is clarified that the content of the analysis does not constitute legal or tax advice relating to the investment in investment funds and/or a particular fund. Each investor is advised to consult with other competent advisors to evaluate the investment in the fund.
Any investment in the fund must only be made in accordance with the legal documents of the fund and the terms and conditions contained therein, after the investor has obtained all relevant legal documents, reviewed them in person, at his own expense, and signed them.
Each analysis contains projections, estimates, and other forward-looking information, the materialization of which is uncertain. Facts and data contained in each analysis are as of the date the analysis was performed, without any certainty that the projections and estimates described therein would materialize. Moreover, the results of such projections and estimates may be materially different than those described in the analysis.
The Company and/or any of its executives and/or representatives and/or anyone acting on its behalf assumes no liability for any direct or circumstantial loss resulting from the investment in the funds under review.
The analyses published on the Website are the exclusive property of Objective. No document or analysis contained on the Website may in whole or in part be copied, distributed or transferred, and the information contained on the Website may not, in whole or in part, be disclosed to third parties by any means whatsoever.